Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prostate Cancer
100%
MiR-375
100%
Yes-associated Protein 1 (YAP1)
100%
Docetaxel Resistance
100%
SEC23A
100%
Docetaxel
26%
Chemoresistance
17%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
13%
Cancer Genome Atlas
13%
Fold Increase
8%
Expression Level
8%
Cancer Tissue
8%
Apoptotic Cells
8%
Normal Prostate
8%
Docetaxel Chemotherapy
8%
Overexpressing
4%
Tumor
4%
Reduced Cell
4%
Quantitative PCR
4%
Protein Level
4%
MRNA Level
4%
Therapeutic Target
4%
Cell Growth
4%
Treatment Options
4%
High-level Expression
4%
Overexpression
4%
Nude Mice
4%
Tumor Growth
4%
Overall Survival
4%
Prostate Cancer Cell Lines
4%
Tumor Growth Rate
4%
Cell Apoptosis
4%
Prostate Cancer Cells
4%
PC-3
4%
Prostate Cancer Patients
4%
Xenograft Mice
4%
Growth Resistance
4%
Expression Change
4%
Tumor Tissue
4%
Drug Resistance
4%
Lentiviral Vector
4%
Prostate Tissue
4%
Tumor Weight
4%
PC-3 Cells
4%
Cell Sensitivity
4%
Western Blot Assay
4%
Predictive Biomarker
4%
DU145
4%
Dual Role
4%
Cancer Proliferation
4%
Cancer Stage
4%
Vector Control
4%
Cell Growth Inhibition
4%
Dataset Analysis
4%
Atlas Data
4%
Prostate Cancer Cell Line DU145
4%
Pre-miRNA
4%
Immunology and Microbiology
Drug Resistance
100%
Prostate
80%
Cell Growth
40%
Cancer Tissue
40%
Prostate Cancer Cell Line
40%
Nude Mouse
20%
Western Blot
20%
Cancer Cell
20%
Quantitative Reverse Transcription Polymerase Chain Reaction
20%
Programmed Cell Death
20%
Genetic Transfection
20%
Xenograft
20%
Lentivirus Vector
20%
Overall Survival
20%
Growth Inhibition
20%
Cancer Staging
20%
Prostate Tissue
20%
In Vitro
20%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Docetaxel
100%
microRNA 375
100%
Drug Resistance
21%
Malignant Neoplasm
13%
Neoplasm
8%
Tumor Growth
8%
Chemotherapy
8%
Messenger RNA
4%
Nude Mouse
4%
Western Blot
4%
Overall Survival
4%
microRNA
4%
Biological Marker
4%
Cancer Staging
4%
Lentivirus Vector
4%